Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.15 NOK
7.57 M NOK
104.35 M NOK
44.44 M
About ARCTICZYMES TECHNOLOGIES ASA
Sector
Industry
CEO
Michael B. Akoh
Website
Headquarters
Tromsø
Founded
1990
ISIN
NO0010014632
FIGI
BBG00JHVSLH6
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Corporate segments. The Enzymes segment is composed of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing. The Corporate segment provides a range of administrative services to the subsidiary. The company was founded by Jan Raa and Gunnar Rorstad in November 1990 and is headquartered in Tromso, Norway.
ArcticZymes $AZT Q1 2021 stunning Q1 presentation, up 22% !!!AZTY reported sales of NOK 40.4 million (18.5) and an EBITDA of NOK 25.8 million (9.0) for the first quarter of 2021.
Highlights from Q1 2021
· ArcticZymes Technologies (AZT) had Q1 sales of NOK 40.4 million growing by 119% (Q1 2020: NOK 18.5 million)
· Coronavirus-related sales are estimated a
ArcticZymes $AZT Q3 2020 reportHighlights for Q3 2020
• Annual group sales exceed 100 MNOK for the first time
• Gross profit for the Group improved 65% to NOK 26.0 million (Q3 2019: NOK 15.7 million)
• ArcticZymes had Q3 sales of NOK 19.5 million growing by 63% (Q3 2019: NOK 12.0 million)
• Biotec BetaGlucans had Q3 sales of NOK
ArcticZymes turnaround & firing on all cylindersThe Turnaround of ArcticZymes is now definitive. For the second quarter we see impressive growth and the company is firing on all cylinders. Opex (cost) going down while earnings as well as profits surge.
ArcticZymes Q2 report
Sales of NOK 44.3 million (16.9) +262%
EBITDA of NOK 27.2 million (-
ArcticZymes is the Covid-19 stock that is valued at 197 mUSDArcticZymes has entered into an agreement with ReiThera to supply its SAN product for ReiThera’s COVID-19 vaccine candidate
Tromsø, 02 July, 2020: ArcticZymes AS (OSE:AZT), a subsidiary of ArcticZymes Technologies ASA, announces that it has entered into a supply agreement with vaccine specialist Re
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 0DRV is 14.50 NOK — it has decreased by −13.07% in the past 24 hours. Watch ARCTICZYMES TECHNOLOGIES ASA NOK1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ARCTICZYMES TECHNOLOGIES ASA NOK1 stocks are traded under the ticker 0DRV.
We've gathered analysts' opinions on ARCTICZYMES TECHNOLOGIES ASA NOK1 future price: according to them, 0DRV price has a max estimate of 19.00 NOK and a min estimate of 19.00 NOK. Watch 0DRV chart and read a more detailed ARCTICZYMES TECHNOLOGIES ASA NOK1 stock forecast: see what analysts think of ARCTICZYMES TECHNOLOGIES ASA NOK1 and suggest that you do with its stocks.
0DRV reached its all-time high on Jul 29, 2021 with the price of 108.50 NOK, and its all-time low was 5.35 NOK and was reached on May 10, 2018. View more price dynamics on 0DRV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0DRV stock is 15.03% volatile and has beta coefficient of 0.49. Track ARCTICZYMES TECHNOLOGIES ASA NOK1 stock price on the chart and check out the list of the most volatile stocks — is ARCTICZYMES TECHNOLOGIES ASA NOK1 there?
Today ARCTICZYMES TECHNOLOGIES ASA NOK1 has the market capitalization of 898.86 M, it has decreased by −9.42% over the last week.
Yes, you can track ARCTICZYMES TECHNOLOGIES ASA NOK1 financials in yearly and quarterly reports right on TradingView.
ARCTICZYMES TECHNOLOGIES ASA NOK1 is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
0DRV earnings for the last quarter are 0.06 NOK per share, whereas the estimation was −0.0034 NOK resulting in a 1.87 K% surprise. The estimated earnings for the next quarter are 0.035 NOK per share. See more details about ARCTICZYMES TECHNOLOGIES ASA NOK1 earnings.
ARCTICZYMES TECHNOLOGIES ASA NOK1 revenue for the last quarter amounts to 25.25 M NOK, despite the estimated figure of 25.75 M NOK. In the next quarter, revenue is expected to reach 26.35 M NOK.
0DRV net income for the last quarter is 3.29 M NOK, while the quarter before that showed −1.56 M NOK of net income which accounts for 311.17% change. Track more ARCTICZYMES TECHNOLOGIES ASA NOK1 financial stats to get the full picture.
No, 0DRV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARCTICZYMES TECHNOLOGIES ASA NOK1 EBITDA is 5.25 M NOK, and current EBITDA margin is 5.03%. See more stats in ARCTICZYMES TECHNOLOGIES ASA NOK1 financial statements.
Like other stocks, 0DRV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARCTICZYMES TECHNOLOGIES ASA NOK1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARCTICZYMES TECHNOLOGIES ASA NOK1 technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARCTICZYMES TECHNOLOGIES ASA NOK1 stock shows the sell signal. See more of ARCTICZYMES TECHNOLOGIES ASA NOK1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.